Latrobe Regional Health (LRH) is at the forefront of a world-first clinical trial set to improve outcomes for patients with advanced or metastatic melanoma.
2023
Roundtable Roundup: Skin Cancer
In separate live, virtual events, Hussein A. Tawbi, MD, PhD; and Allison Betof Warner, MD, PhD, discuss potential treatment options for a patient with BRAF mutation–negative melanoma.
Melanoma vaccine: final tests on Moderna’s mRNA in combination with immunotherapy
The final phase of clinical trials of Moderna’s V940 anti-melanoma vaccine is underway, in combination with Merck’s Keytruda immunotherapy.
In Weicksel Lab, students seek to identify new genes involved with melanoma
It’s a Thursday morning in July and Lauren Rothwell ’26 sits in one of Bryant’s research labs concentrating on a row of vials. Hovering a pipette over the third glass tube, she is busy setting up glycerol stocks to freeze bacteria.